Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2024-12-19

FDA Approved: ABACAVIR AND LAMIVUDINE — Original Application (Macleods Pharmaceuticals Limited)

View source ↗

Summary

FDA approved a generic combination tablet of abacavir and lamivudine through an Original Application filed by Macleods Pharmaceuticals Limited.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ABACAVIR AND LAMIVUDINE (abacavir/lamivudine)

Snippet

ORIG AP for ABACAVIR AND LAMIVUDINE (ABACAVIR AND LAMIVUDINE)